Home       Market Dynamics     Sector Analysis     Company Insights     AI Investing     Strategies     Contact Us     Login             

ABBVIE INC (ABBV) Stock Price Prediction and News Highlight
Fri. Nov 28, 2025

Recent advancements in AbbVie's product development are highlighted by the positive reimbursement recommendation for SKYRIZI in ulcerative colitis, showcasing their commitment to innovation. The successful growth in immunology sales further indicates AbbVie's strategic focus amidst a competitive environment. However, ongoing challenges in the pharmaceutical sector, such as market competition and regulatory hurdles, could affect future product development pathways.

The price action of ABBVIE INC (ABBV) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 1 is bullish. The market sentiment at 1.1 is very bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.ABBV is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 1.1, and the negative at 0 on 2025-11-28. The forces of Sentiment towards Fundamentals (3.4), Market Risk Appetite (1), Sector Price Trend (1), Stock Price Trend (1), Valuation Sentiment (0.6), Option Sentiment (0), and Price Level Sentiment (0) will drive up the price. The forces of and Price Level Sentiment (0) will drive down the price.

The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band.

Earning Release: 2026-01-29 10:00, EPS: $1.32, P/E: 172.5

ABBV
DateAttentionPricePrice
Level
ChangeSMA10
Trend
Trend
Sentiment
Hourly
Trend
Hourly
StdDev
Market
Sentiment
ActionPFund.News
Sentiment
2025-11-280%(0%)    1    0.25%    1.1          3.4    -1   
2025-11-270%(0%)    1    0.25%    1.1          3.3    -1   
2025-11-260%(0%)    1    0.25%    1.1          3.3    -1   
2025-11-250%(0%)    1    0.25%    1.1          3.5    -1   
2025-11-240%(0%)    1    0.25%    1.2          3.8    -1   
2025-11-230%(0%)    1    0.25%    1.2          3.4    -1   
2025-11-220%(0%)    1    0.25%    1.2          3.1    -1   
2025-11-210%(0%)    1    0.25%    1          3.5    -1   
2025-11-200%(0%)    1    0.25%    0.6          1.2    -1   
2025-11-190%(0%)    1    0.25%    0.6          1.4    -1   
 
Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position.
Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force.

2025-11-28 17:03:11 SKYRIZI represents innovation in the treatment landscape for ulcerative colitis, following previous successes in treating Crohn's disease.
2025-11-28 17:03:11 AbbVie's stock shows a slight increase, reflecting investor confidence amidst positive news about its drug approvals.
2025-11-28 17:03:11 AbbVie's collaboration with the pan-Canadian Pharmaceutical Alliance shows increasing partnerships aimed at improving healthcare outcomes.
2025-11-28 17:03:11 The approval and recommendations given by regulatory bodies like the Canadian drug agency significantly affect the pharmaceutical market and patient access to new treatments.
2025-11-28 17:03:11 AbbVie's SKYRIZI has received a positive reimbursement recommendation for ulcerative colitis from Canada's drug agency, indicating strong advancements in treatment options.


About   Contact Us  
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA